Ixiaro to prevent Japanese Encephalitis approved in Europe
European Commission grants marketing authorization for Intercell?s IXIARO, the first licensed vaccine against Japanese Encephalitis for travelers and military personnel in Europe. – Intercell AG (VSE: ICLL) announced that its new vaccine to prevent Japanese Encephalitis, IXIARO, has been approved by the European Commission.